Clinical Trial Update: Vortioxetine in Patients With Major Depressive Disorder and Coronary Artery Disease [EARLY_Phase 1]

View source ↗

Summary

The early-phase trial of vortioxetine in patients with major depressive disorder and coronary artery disease was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Major Depressive Disorder

Drugs mentioned

• Vortioxetine (vortioxetine)

Snippet

Sponsor: Thomas Jefferson University | Conditions: Major Depressive Disorder, Coronary Artery Disease | EARLY_Phase 1 | Status: WITHDRAWN